Skip to content

Home Blood Pressure Study for Recent Stroke Survivors With High Blood Pressure *On Hold Due to Global Pandemic*

Home Blood Pressure Self-Management in Hypertensive Stroke Survivors: a Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04226157
Acronym
HBPS
Enrollment
32
Registered
2020-01-13
Start date
2019-02-21
Completion date
2021-03-31
Last updated
2020-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Ischemic Stroke

Keywords

Blood Pressure, Stroke, Hypertension, Blood Pressure Monitor, Home Blood Pressure Monitor, Ischemic Stroke, Stroke Prevention

Brief summary

The purpose of this pilot study is to assess the feasibility of implementing a home blood pressure self-management program in a population of recent stroke survivors in the Washington, D.C. area. The investigators hypothesize that hypertensive stroke survivors in the Washington, DC area who participate in the Home Blood Pressure Monitoring program will have a greater reduction in mean systolic blood pressure (SBP) from baseline to 3 months, as measured by automated office blood pressure (AOBP), as compared to usual care.

Detailed description

The purpose of this trial is to determine if a home blood pressure self-management (HBPS) program, including home monitoring and medication adjustments, is practical to use in recent stroke survivors and whether or not it is associated with lowering blood pressure after 3 months. Data from this trial may be used to do more research and may be used by doctors when seeing patients.This research is being done because high blood pressure, also called hypertension, is the leading risk factor for stroke. Lowering blood pressure (BP) has been shown to lower the risk of future strokes. The majority of stroke survivors continue to have uncontrolled BP. Currently, blood pressure (BP) is most often measured in the doctor's office. However, those single BP measurements are not the best picture of blood pressure over time and can be influenced by the stress of being in a doctor's office, known as the white coat effect. This is why measuring BP at home may paint a more accurate picture of a patient's true long-term BP. Home blood pressure monitoring (HBPM) is recommended in the recently updated national hypertension guidelines. Home BP monitoring plus guided BP medication self-adjustments is associated with lower BP in patients with high blood pressure. The investigators believe that a HBPS program, including medication self-adjustment and home monitoring, may help to reduce blood pressure in patients with hypertension within 3 months.

Interventions

DEVICEHome Blood Pressure Monitoring Device (Qardio Arm)

The Home Blood Pressure Device with telemonitoring capability will allow the participants and physician to monitor blood pressure over time and titrate blood pressure medications as needed for persistently elevated blood pressure.

OTHERPrimary Care Provider Blood Pressure Management

Participant will follow up as would normally do with primary care provider for blood pressure management.

Sponsors

Medstar Health Research Institute
CollaboratorOTHER
MedStar Georgetown University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Patients with hypertension who have had a stroke within the past 6 months will be randomized into two groups in a one to one ratio: Home Blood Pressure Self-Management (HBPS) or Usual Care.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute ischemic stroke in the past 180 days of screening * Age \>/= 18 years old * Automated Office Blood Pressure ≥135 systolic or ≥85 diastolic at time of screening * Stage 2 hypertension (as defined by \>140 mmHg SBP and or \>90 mmHg DBP on 2 occasions or history of hypertension prior to stroke or currently taking antihypertensive medications) * Able to live independently (as defined by modified Rankin scale score of 0-2)

Exclusion criteria

* CKD stage IV or greater (GFR \< 30) * Inability to check BP in either arm (e.g. amputation, lymphedema) * Pregnancy * High-grade intracranial or extracranial stenosis requiring a higher BP goal * Unable to provide informed consent for themselves in English or Spanish * Life expectancy less than 12 months

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of blood pressure self management in stroke survivorsThree MonthsAt least 75 percent of HBPS participants will successfully complete the monitoring and self-titration intervention.

Secondary

MeasureTime frameDescription
Systolic Blood Pressure Differencethree monthsDifference in systolic blood pressure from baseline to three months between HBPS and Usual Care arms.

Countries

United States

Contacts

Primary ContactMary Carter Denny, MD
MaryCarter.Denny@medstar.net202-444-8532

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026